Statistics

Total Visits

Views
Post -Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) of High -Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Adult Acute Lymphoblastic Leukemia (ALL) According to Minimal Residual Disease (MRD).20

Select a period of time:

Number of views in the range

Views
Post -Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) of High -Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Adult Acute Lymphoblastic Leukemia (ALL) According to Minimal Residual Disease (MRD).14

Views

Views
October 20240
November 20240
December 20240
January 20250
February 20250
March 202514
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
United States1
 

Top cities views

Views